CAG
RXL icon

Csenge Advisory Group’s ProShares Ultra Health Care RXL Stock Holding History

Csenge Advisory Group’s Portfolio RXL Stock Details RXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,734
Closed -$297K – 804
2025
Q4 		$297K Buy
+5,734
New +$280K 0.01% 568

Other funds holding RXL

IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Csenge Advisory Group's RXL Position: Q1 2026 in Review

Csenge Advisory Group sold out of ProShares Ultra Health Care (RXL) in Q1 2026, closing a stake of 5,734 shares — an estimated $297K sold.

Csenge Advisory Group first reported a position in RXL in Q4 2025 and held it in 1 quarter. The position peaked at $297K in Q4 2025. 17 funds tracked by Wall St. Rank hold RXL as of Q1 2026.

  • Csenge Advisory Group reported no remaining ProShares Ultra Health Care position as of Q1 2026 after selling out during the quarter.
  • Csenge Advisory Group sold 5,734 ProShares Ultra Health Care shares in Q1 2026, an estimated $297K.
  • Csenge Advisory Group first reported a position in ProShares Ultra Health Care in Q4 2025 and held it in 1 quarter.
  • Csenge Advisory Group's ProShares Ultra Health Care position peaked at $297K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.